Stratos Wealth Partners, Ltd. Rhythm Pharmaceuticals, Inc. Transaction History

Stratos Wealth Partners, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$21.39 - $49.64 $176,724 - $410,125	-8,262 Reduced 53.21%	7,264 $333,000
Q3 2023 Oct 24, 2023	SELL	$15.81 - $27.8 $206,446 - $363,012	-13,058 Reduced 45.68%	15,526 $355,000
Q2 2023 Jul 18, 2023	SELL	$16.32 - $21.15 $416,160 - $539,325	-25,500 Reduced 47.15%	28,584 $471,000
Q1 2023 Apr 27, 2023	SELL	$16.88 - $34.24 $324,703 - $658,640	-19,236 Reduced 26.24%	54,084 $964,000
Q4 2022 Jan 19, 2023	BUY	$22.21 - $30.25 $770,798 - $1.05 Million	34,705 Added 89.87%	73,320 $0
Q3 2022 Oct 24, 2022	BUY	$4.3 - $30.85 $166,044 - $1.19 Million	38,615 New	38,615 $946,000

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.